Melline G.M. Schilham

Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study

Bastiaan M. Privé, Steffie M. B. Peters, Inge M. van Oort et al. · Clinical Cancer Research · 2021 · 89 citations · Full text

Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology

Bastiaan M. Privé, Bas Israël, Melline G.M. Schilham et al. · Prostate Cancer and Prostatic Diseases · 2020 · 66 citations

Urology, Oncologic Imaging, Medical Imaging +11

Head-to-Head Comparison of ⁶⁸Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients

Melline G.M. Schilham, Patrik Zámecnik, Bastiaan M. Privé et al. · Journal of Nuclear Medicine · 2021 · 37 citations · Full text

Preoperative PSMA-PET/CT as a predictor of biochemical persistence and early recurrence following radical prostatectomy with lymph node dissection

D.J.H. Baas, Melline G.M. Schilham, Rick Hermsen et al. · Prostate Cancer and Prostatic Diseases · 2021 · 29 citations

Early Recurrence, Urology, Surgical Oncology +8

Prostate-Specific Membrane Antigen–Targeted Radioguided Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients with a Suspicion of Locoregional Lymph Node Metastases: The DETECT Trial

Melline G.M. Schilham, Diederik M. Somford, Heidi V.N. Küsters‐Vandevelde et al. · Journal of Nuclear Medicine · 2024 · 22 citations · Full text